首页> 外文期刊>The Journal of Urology >Nifedipine versus tamsulosin for the management of lower ureteral stones.
【24h】

Nifedipine versus tamsulosin for the management of lower ureteral stones.

机译:硝苯地平与坦索罗辛治疗下输尿管结石。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We evaluate and compare the effectiveness of 2 different medical therapies during watchful waiting in patients with lower ureteral stones. MATERIALS AND METHODS: A total of 86 patients with stones less than 1 cm located in the lower ureter (juxtavesical or intramural tract) were enrolled in the study and were randomly divided into 3 groups. Group 1 (30) and 2 (28) patients received daily oral treatment of 30 mg deflazacort, (maximum 10 days). In addition group 1 patients received 30 mg nifedipine slow-release (maximum 28 days) and group 2 received 1 daily oral therapy of 0.4 mg tamsulosin (maximum 28 days), Group 3 patients (28) were used as controls. Statistical analyses were performed using Student's test, ANOVA test, chi-square test and Fisher's exact test. RESULTS: The average stone size for groups 1 to 3 was 4.7, 5.42 and 5.35 mm, respectively, which was not statistically significant. Expulsion was observed in 24 of 30 patients in group 1 (80%), 24 of 28 in group 2 (85%) and 12 of 28 in group 3 (43%). The difference in groups 1 and 2 with respect to group 3 was significant. Average expulsion time for groups 1 to 3 was 9.3, 7.7 and 12 days, respectively. A statistically significant difference was noted between groups 2 and 3. Mean sodium diclofenac dosage per patient in groups 1 to 3 was 19.5, 26, and 105 mg, respectively. A statistical significant difference was observed between groups 1 and 2 with respect to group 3. CONCLUSIONS: Medical treatments with nifedipine and tamsulosin proved to be safe and effective as demonstrated by the increased stone expulsion rate and reduced need for analgesic therapy. Moreover medical therapy, particularly in regard to tamsulosin, reduced expulsion time.
机译:目的:我们评估并比较了在输尿管下段结石患者观察等待期间两种不同药物疗法的有效性。材料与方法:共有86例位于输尿管下段(近膀胱或壁内)结石小于1 cm的患者入选,并随机分为3组。第1(30)和2(28)组患者每天接受30 mg的deflazacort口服治疗(最长10天)。此外,第1组患者接受30 mg硝苯地平缓释药(最长28天),第2组每天接受1次口服0.4 mg坦索罗辛的口服治疗(最长28天),第3组患者(28)作为对照。使用学生检验,方差分析,卡方检验和费舍尔精确检验进行统计分析。结果:第1至第3组的平均结石大小分别为4.7、5.42和5.35 mm,但无统计学意义。第一组的30例患者中有24例被驱逐(80%),第二组的28例中有24例(85%),第三组的28例中有12例(43%)。第1组和第2组相对于第3组的差异是显着的。第1-3组的平均驱逐时间分别为9.3、7.7和12天。在第2组和第3组之间发现统计学上的显着差异。第1至3组中每位患者的双氯芬酸钠平均剂量分别为19.5、26和105 mg。在第1组和第2组之间,相对于第3组,观察到统计学上的显着差异。结论:硝苯地平和坦索罗辛的药物治疗被证明是安全有效的,如结石排出率增加和对止痛药的需求减少所证明。此外,药物治疗,特别是坦洛新的治疗,减少了驱逐时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号